Preoperative Radiomics Nomogram Based on CT Image Predicts Recurrence-Free Survival After Surgical Resection of Hepatocellular Carcinoma

Published:January 16, 2023DOI:

      Rationale and Objectives

      To construct preoperative models based on CT radiomics, radiologic and clinical features to predict recurrence-free survival (RFS) after liver resection (LR) of BCLC 0 to B stage hepatocellular carcinoma (HCC) and to classify the prognosis.

      Materials and Methods

      This study retrospectively analyzed 161 HCC patients who underwent radical LR. Two methods, the least absolute shrinkage and selection operator and random survival forest analysis, were performed for radiomics signature (RS) construction. Univariate and multivariate stepwise Cox regression analyses were performed to establish a combined nomogram (RCN) of RS and clinical parameters and a clinical nomogram (CN). The performance of the models was assessed comprehensively using Harrell's concordance index (C-index), the calibration curve, and decision curve analysis. The discrimination accuracy of the models was compared using integrated discrimination improvement index (IDI). The risk stratification effect was assessed with Kaplan–Meier survival analysis and subgroup analysis.


      The RCN achieved a C-index of 0.792/0.758 in the training/validation set, which was higher than the CN, RS, and BCLC stage system. The discriminatory accuracy of the RCN was improved when compared to the CN, RS, and BCLC staging systems (IDI > 0). Decision curve analysis reflected the clinical net benefit of the RCN. The RCN allows risk stratification of patients in different clinical subgroups.


      The integrated model combining RS and clinical factors can more effectively predict RFS after LR of BCLC 0 to B stage HCC patients and can effectively stratify the prognostic risk.

      Key Words

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Academic Radiology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Bray F
        • Ferlay J
        • Soerjomataram I
        • et al.
        Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.
        CA Cancer J Clin. 2018; 68: 394-424
        • Heimbach J K
        • Kulik L M
        • Finn R S
        • et al.
        AASLD guidelines for the treatment of hepatocellular carcinoma.
        Hepatology. 2018; 67: 358-380
        • Wada H
        • Eguchi H
        • Noda T
        • et al.
        Selection criteria for hepatic resection in intermediate-stage (BCLC stage B) multiple hepatocellular carcinoma.
        Surgery. 2016; 160: 1227-1235
        • Moris D
        • Felekouras E.
        Ignore reality but not the consequences of its ignorance: broaden guidelines in surgery of hepatocellular carcinoma.
        Hepatology. 2017; 65: 1772-1773
        • Vitale A
        • Burra P
        • Frigo A C
        • et al.
        Survival benefit of liver resection for patients with hepatocellular carcinoma across different Barcelona Clinic Liver Cancer stages: a multicentre study.
        J Hepatol. 2015; 62: 617-624
        • Yang B
        • Zheng B
        • Yang M
        • et al.
        Liver resection versus transarterial chemoembolization for the initial treatment of Barcelona Clinic Liver Cancer stage B hepatocellular carcinoma.
        Hepatol Int. 2018; 12: 417-428
        • Labgaa I
        • Taffé P
        • Martin D
        • et al.
        Comparison of partial hepatectomy and transarterial chemoembolization in intermediate-stage hepatocellular carcinoma: a systematic review and meta-analysis.
        Liver Cancer. 2020; 9: 138-147
        • Lim K C
        • Chow P K
        • Allen J C
        • et al.
        Systematic review of outcomes of liver resection for early hepatocellular carcinoma within the Milan criteria.
        Br J Surg. 2012; 99: 1622-1629
        • Toyoda H
        • Lai P B
        • O'Beirne J
        • et al.
        Long-term impact of liver function on curative therapy for hepatocellular carcinoma: application of the ALBI grade.
        Br J Cancer. 2016; 114: 744-750
        • Ang S F
        • Ng E S
        • Li H
        • et al.
        The Singapore Liver Cancer Recurrence (SLICER) Score for relapse prediction in patients with surgically resected hepatocellular carcinoma.
        PLoS One. 2015; 10e118658
        • Huang S
        • Huang G Q
        • Zhu G Q
        • et al.
        Establishment and Validation of SSCLIP scoring system to estimate survival in hepatocellular carcinoma patients who received curative liver resection.
        PLoS One. 2015; 10e129000
        • Chan A
        • Zhong J
        • Berhane S
        • et al.
        Development of pre and post-operative models to predict early recurrence of hepatocellular carcinoma after surgical resection.
        J Hepatol. 2018; 69: 1284-1293
        • Bi W L
        • Hosny A
        • Schabath M B
        • et al.
        Artificial intelligence in cancer imaging: clinical challenges and applications.
        CA Cancer J Clin. 2019; 69: 127-157
        • Lambin P
        • Leijenaar R
        • Deist T M
        • et al.
        Radiomics: the bridge between medical imaging and personalized medicine.
        Nat Rev Clin Oncol. 2017; 14: 749-762
        • Ji G W
        • Zhu F P
        • Xu Q
        • et al.
        Radiomic features at contrast-enhanced CT predict recurrence in early stage hepatocellular carcinoma: a multi-institutional study.
        Radiology. 2020; 294: 568-579
        • Ji G W
        • Zhu F P
        • Xu Q
        • et al.
        Machine-learning analysis of contrast-enhanced CT radiomics predicts recurrence of hepatocellular carcinoma after resection: a multi-institutional study.
        EBioMedicine. 2019; 50: 156-165
        • Zheng B H
        • Liu L Z
        • Zhang Z Z
        • et al.
        Radiomics score: a potential prognostic imaging feature for postoperative survival of solitary HCC patients.
        BMC Cancer. 2018; 18: 1148
        • Kim S
        • Shin J
        • Kim D Y
        • et al.
        Radiomics on gadoxetic acid-enhanced magnetic resonance imaging for prediction of postoperative early and late recurrence of single hepatocellular carcinoma.
        Clin Cancer Res. 2019; 25: 3847-3855
        • Hui T
        • Chuah T K
        • Low H M
        • et al.
        Predicting early recurrence of hepatocellular carcinoma with texture analysis of preoperative MRI: a radiomics study.
        Clin Radiol. 2018; 73: 1011-1056
        • Zhang Z
        • Jiang H
        • Chen J
        • et al.
        Hepatocellular carcinoma: radiomics nomogram on gadoxetic acid-enhanced MR imaging for early postoperative recurrence prediction.
        Cancer Imaging. 2019; 19: 22
        • Ji G W
        • Zhang Y D
        • Zhang H
        • et al.
        Biliary tract cancer at CT: a radiomics-based model to predict lymph node metastasis and survival outcomes.
        Radiology. 2019; 290: 90-98
        • Tibshirani R.
        The lasso method for variable selection in the Cox model.
        Stat Med. 1997; 16: 385-395
        • Huang Y
        • Liu Z
        • He L
        • et al.
        Radiomics signature: a potential biomarker for the prediction of disease-free survival in early-stage (I or II) non-small cell lung cancer.
        Radiology. 2016; 281: 947-957
        • Shim J H
        • Jun M J
        • Han S
        • et al.
        Prognostic nomograms for prediction of recurrence and survival after curative liver resection for hepatocellular carcinoma.
        Ann Surg. 2015; 261: 939-946
        • Taylor J M
        Random survival forests.
        J Thorac Oncol. 2011; 6: 1974-1975
        • O Brien R M
        A Caution regarding rules of thumb for variance inflation factors.
        Qual & Quant. 2007; 41: 673-690
        • Hayashi K
        • Eguchi S.
        The power-integrated discriminant improvement: an accurate measure of the incremental predictive value of additional biomarkers.
        Stat Med. 2019; 38: 2589-2604
        • Vickers A J
        • Elkin EB
        Decision curve analysis: a novel method for evaluating prediction models.
        Med Decis Making. 2006; 26: 565-574
        • Dagogo-Jack I
        • Shaw A T
        Tumour heterogeneity and resistance to cancer therapies.
        Nat Rev Clin Oncol. 2018; 15: 81-94
      1. Miao F, Cai YP, Zhang Y T. Is random survival forest an alternative to cox proportional model on predicting cardiovascular disease?, 6th European Conference of the International Federation for Medical and Biological Engineering: MBEC 2014, 7-11 September 2014, Dubrovnik, Croatia, 2015, 740–743.

        • Liu Z
        • Li Z
        • Qu J
        • et al.
        Radiomics of multiparametric MRI for pretreatment prediction of pathologic complete response to neoadjuvant chemotherapy in breast cancer: a multicenter study.
        Clin Cancer Res. 2019; 25: 3538-3547
        • Yang P
        • Yang Y H
        • Zhou B B
        • et al.
        A review of ensemble methods in bioinformatics.
        Curr Bioinform. 5 (4), 2010; : 296-308
        • Aerts H J
        • Velazquez E R
        • Leijenaar R T
        • et al.
        Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach.
        Nat Commun. 2014; 5: 4006
        • Tsilimigras D I
        • Bagante F
        • Sahara K
        • et al.
        Prognosis after resection of Barcelona Clinic Liver Cancer (BCLC) stage 0, A, and B hepatocellular carcinoma: a comprehensive assessment of the current BCLC classification.
        Ann Surg Oncol. 2019; 26: 3693-3700
        • Lin C W
        • Chen Y S
        • Lo G H
        • et al.
        Comparison of overall survival on surgical resection versus transarterial chemoembolization with or without radiofrequency ablation in intermediate stage hepatocellular carcinoma: a propensity score matching analysis.
        BMC Gastroenterol. 2020; 20: 99
        • Shan Q Y
        • Hu H T
        • Feng S T
        • et al.
        CT-based peritumoral radiomics signatures to predict early recurrence in hepatocellular carcinoma after curative tumor resection or ablation.
        Cancer Imaging. 2019; 19: 11
        • Ho S Y
        • Liu P H
        • Hsu C Y
        • et al.
        A new tumor burden score and albumin-bilirubin grade-based prognostic model for hepatocellular carcinoma.
        Cancers (Basel). 2022; 14: 649
        • Cheng Z
        • Yang P
        • Qu S
        • et al.
        Risk factors and management for early and late intrahepatic recurrence of solitary hepatocellular carcinoma after curative resection.
        HPB (Oxford). 2015; 17: 422-427
        • Kudo M.
        Newly developed modified albi grade shows better prognostic and predictive value for hepatocellular carcinoma.
        Liver Cancer. 2022; 11: 1-8
        • Lim J H
        • Choi D
        • Park C K
        • et al.
        Encapsulated hepatocellular carcinoma: CT-pathologic correlations.
        Eur Radiol. 2006; 16 ([): 2326-2333
        • Lim K C
        • Chow P K
        • Allen J C
        • et al.
        Microvascular invasion is a better predictor of tumor recurrence and overall survival following surgical resection for hepatocellular carcinoma compared to the Milan criteria.
        Ann Surg. 2011; 254: 108-113
        • Johnson P J
        • Berhane S
        • Kagebayashi C
        • et al.
        Assessment of liver function in patients with hepatocellular carcinoma: a new evidence-based approach-the ALBI grade.
        J Clin Oncol. 2015; 33: 550-558
        • Ho S Y
        • Hsu C Y
        • Liu P H
        • et al.
        Albumin-bilirubin grade-based nomogram of the BCLC system for personalized prognostic prediction in hepatocellular carcinoma.
        Liver Int. 2020; 40: 205-214
      2. Ho S Y, Hsu C Y, Liu P H, et al., Survival of patients with hepatocellular carcinoma in renal insufficiency: prognostic role of albumin-bilirubin grade, Cancers (Basel), 2020; 12(5):1130.

        • Wands J.
        Hepatocellular carcinoma and sex.
        N Engl J Med. 2007; 357: 1974-1976
        • El-Serag H B
        Epidemiology of viral hepatitis and hepatocellular carcinoma.
        Gastroenterology. 2012; 142: 1264-1273
        • Banerjee S
        • Wang D S
        • Kim H J
        • et al.
        A computed tomography radiogenomic biomarker predicts microvascular invasion and clinical outcomes in hepatocellular carcinoma.
        Hepatology. 2015; 62: 792-800
        • Renzulli M
        • Brocchi S
        • Cucchetti A
        • et al.
        Can current preoperative imaging be used to detect microvascular invasion of hepatocellular carcinoma?.
        Radiology. 2016; 279: 432-442